DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR ATENOLOL
Clinical Trials for Atenolol
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT00000478 | Asymptomatic Cardiac Ischemia Pilot (ACIP) Study | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | To assess the feasibility of and test the methodology for a full-scale clinical trial of therapies for asymptomatic cardiac ischemia. |
| NCT00000513 | Trial of Antihypertensive Intervention Management | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | The objective of the Trial of Antihypertensive Intervention Management (TAIM) was to determine the efficacy of dietary management and/or drug therapy, namely thiazide-like diuretics or a beta-blocker, in the control of mild hypertension. Additionally, the Continuation of the Trial of Antihypertensive Intervention Management (COTAIM) tested the effects of long-term weight reduction, and sodium/potassium changes added to weight reduction, as well as the original drug treatment, on the failure rate of blood pressure control. |
| NCT00000514 | Systolic Hypertension in the Elderly Program (SHEP) | Completed | National Institute on Aging (NIA) | Phase 3 | The primary objective was to assess whether long-term administration of antihypertensive therapy to elderly subjects with isolated systolic hypertension reduced the combined incidence of fatal and non-fatal stroke. The secondary objectives were to evaluate: the effect of long-term antihypertensive therapy on mortality from any cause in elderly people with isolated systolic hypertension; possible adverse effects of chronic use of antihypertensive drug treatment in this population; the effect of therapy on indices of quality-of-life; the natural history of isolated systolic hypertension in the placebo population. |
| NCT00000514 | Systolic Hypertension in the Elderly Program (SHEP) | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | The primary objective was to assess whether long-term administration of antihypertensive therapy to elderly subjects with isolated systolic hypertension reduced the combined incidence of fatal and non-fatal stroke. The secondary objectives were to evaluate: the effect of long-term antihypertensive therapy on mortality from any cause in elderly people with isolated systolic hypertension; possible adverse effects of chronic use of antihypertensive drug treatment in this population; the effect of therapy on indices of quality-of-life; the natural history of isolated systolic hypertension in the placebo population. |
| Trial ID | Title | Status | Sponsor | Phase | Summary |
Clinical Trial Conditions for Atenolol
Condition Name
Condition MeSH
Clinical Trial Locations for Atenolol
Trials by Country
Clinical Trial Progress for Atenolol
Clinical Trial Phase
Clinical Trial Sponsors for Atenolol
Sponsor Name
